Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38.5Revenue $M--Net Margin (%)--Altman Z-Score-5.8
Enterprise Value $M13.3EPS $-0.9Operating Margin %--Piotroski F-Score4
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %-5.8Quick Ratio19.4Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %5.4Current Ratio19.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-115.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.0ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with GALT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GALTGeorge Soros 2014-06-30 Sold Out -0.01%$10.23 - $14.81
($12.43)
$ 1.33-89%Sold Out0
GALTGeorge Soros 2014-03-31 Buy 0.01%$8.025 - $18.3
($14.02)
$ 1.33-91%New holding48,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GALT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GALT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CZIRR JAMES CDirector 2016-04-20Sell44,312$1.67-20.36view
10X Fund, L.P.10% Owner 2016-04-20Sell44,312$1.67-20.36view
Greenberg ArthurDirector 2016-01-05Buy1,666$1.72-22.67view
AMELIO GILBERT FDirector 2015-11-30Sell100$2.1-36.67view
TRABER PETER GPresident & CEO 2015-08-12Buy2,000$2-33.5view
TRABER PETER GPresident & CEO 2015-06-01Buy4,000$2.53-47.43view
FREEMAN KEVIN DDirector 2015-06-01Buy2,083$2.7-50.74view
AMELIO GILBERT FDirector 2014-12-15Sell110$3.69-63.96view
Greenberg ArthurDirector 2014-08-19Buy1,000$4.56-70.83view
FREEMAN KEVIN DDirector 2014-08-15Buy1,000$4.7-71.7view

Press Releases about GALT :

Quarterly/Annual Reports about GALT:

News about GALT:

Articles On GuruFocus.com
No related article found.

More From Other Websites
Edited Transcript of GALT earnings conference call or presentation 15-Mar-16 12:30pm GMT Apr 12 2016
Galectin Therapeutics to Present at Needham & Company's 15th Annual Healthcare Conference Apr 07 2016
Galectin Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference Apr 07 2016
GALECTIN THERAPEUTICS INC Financials Mar 18 2016
Galectin Therapeutics Reports 2015 Financial Results and Provides Business Update Mar 15 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 15 2016
GALECTIN THERAPEUTICS INC Files SEC form 10-K, Annual Report Mar 15 2016
Q4 2015 Galectin Therapeutics Inc Earnings Release - Time Not Supplied Mar 15 2016
Galectin Therapeutics to Hold Business Update Conference Call on March 15 Mar 08 2016
Galectin Therapeutics to Present at the 28th Annual ROTH Conference Mar 07 2016
Galectin Therapeutics Receives U.S. Patent Allowance for GR-MD-02 to Treat Pulmonary Fibrosis Feb 24 2016
Galectin Therapeutics to Present at Upcoming Conferences Jan 28 2016
Galectin Therapeutics Inc., to Present at Noble Financial Capital Markets' 12th Annual Investor... Jan 14 2016
Galectin Therapeutics Appoints Dr. Marc Rubin Chairman of the Board of Directors Jan 08 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other... Jan 08 2016
Galectin Therapeutics Posts "2015-2016, Progress and Possibilities" to Corporate Website Jan 07 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 07 2016
Galectin Therapeutics Announces Dismissals of Federal Securities Class Action and Shareholder... Jan 05 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 05 2016
Is Emmis Communications Corporation (EMMS) A Good Stock To Buy? Nov 23 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)